Devang Gandhi
Overview
Explore the profile of Devang Gandhi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burgess-Hull A, Brooks C, Epstein D, Gandhi D, Oviedo E
J Addict Med
. 2022 Aug;
17(1):28-34.
PMID: 35914118
Objective: Patients receiving medication for opioid use disorder (MOUD) may continue using nonprescribed drugs or have trouble with medication adherence, and it is difficult to predict which patients will continue...
2.
Cole T, Robinson D, Kelley-Freeman A, Gandhi D, Greenblatt A, Weintraub E, et al.
Front Public Health
. 2021 Feb;
8:557275.
PMID: 33553083
Telemedicine is increasingly being used to treat patients with opioid use disorder (OUD). It has particular value in rural areas of the United States impacted by the opioid crisis as...
3.
Greenblatt A, Magidson J, Belcher A, Gandhi D, Weintraub E
Mayo Clin Proc
. 2020 Oct;
95(10):2076-2078.
PMID: 33012340
No abstract available.
4.
Schwartz R, Kelly S, Mitchell S, Gryczynski J, OGrady K, Gandhi D, et al.
Addiction
. 2016 Sep;
112(3):454-464.
PMID: 27661788
Background And Aims: Methadone patients who discontinue treatment are at high risk of relapse, yet a substantial proportion discontinue treatment within the first year. We investigated whether a patient-centered approach...
5.
Kelly S, OGrady K, Jaffe J, Gandhi D, Schwartz R
J Addict Med
. 2013 Mar;
7(2):133-8.
PMID: 23455877
Objective: This secondary data analysis examined the association between criminal justice (CJ) status and outcomes over 12 months of methadone maintenance treatment. Methods: In the parent study, 230 newly admitted...
6.
Chen K, Berger C, Gandhi D, Weintraub E, Lejuez C
J Altern Complement Med
. 2012 Oct;
19(3):204-10.
PMID: 23062020
Objectives: Cocaine addiction continues to be a major public health problem in the United States. With no U.S. Food and Drug Administration-approved pharmaceutical therapy, treatment often relies on psychosocial interventions....
7.
Kelly S, Schwartz R, OGrady K, Gandhi D, Jaffe J
J Addict Med
. 2011 Dec;
6(2):145-52.
PMID: 22134175
Objective: Human immunodeficiency virus (HIV)-risk behaviors were examined at 4- and 12-month follow-up for 230 newly admitted methadone patients randomly assigned to receive either methadone only (n = 99) or...
8.
Schwartz R, Kelly S, OGrady K, Gandhi D, Jaffe J
Addiction
. 2011 Oct;
107(5):943-52.
PMID: 22029398
Aims: This study aimed to determine the relative effectiveness of 12 months of interim methadone (IM; supervised methadone with emergency counseling only for the first 4 months of treatment), standard...
9.
Chen K, Berger C, Forde D, DAdamo C, Weintraub E, Gandhi D
BMC Psychiatry
. 2011 May;
11:90.
PMID: 21595945
Background: Benzodiazepines (BZD) misuse is a serious public health problem, especially among opiate-dependent patients with anxiety enrolled in methadone program because it puts patients at higher risk of life-threatening multiple...
10.
Schwartz R, Kelly S, OGrady K, Gandhi D, Jaffe J
J Subst Abuse Treat
. 2011 Mar;
41(1):21-9.
PMID: 21353445
Interim methadone (IM; with emergency counseling only) is an effective but highly restricted alternative to methadone treatment program (MTP) waiting lists. However, it is not known whether IM disadvantages patients...